Regulus Therapeutics logo

Regulus Therapeutics Share Price Today

(NASDAQ: RGLS)

Regulus Therapeutics share price is $1.35 & ₹117.41 as on 6 Mar 2025, 2.30 'hrs' IST

$1.35

Market is closed - opens 8 PM, 06 Mar 2025

View live Regulus Therapeutics share price in Dollar and Rupees. Guide to invest in Regulus Therapeutics stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Regulus Therapeutics, along with analyst recommendations, forecasts, and comprehensive financials.

Regulus Therapeutics share price movements

  • Today's Low: $1.30
    Today's High: $1.39

    Day's Volatility :6.32%

  • 52 Weeks Low: $0.83
    52 Weeks High: $3.79

    52 Weeks Volatility :78.1%

Regulus Therapeutics (RGLS) Returns

PeriodRegulus Therapeutics IncIndex (Russel 2000)
3 Months
-10.6%
0.0%
6 Months
-13.46%
0.0%
1 Year
-10.0%
0.0%
3 Years
-53.77%
-11.6%

Regulus Therapeutics (RGLS) Key Statistics

in dollars & INR

Previous Close
$1.35
Open
$1.32
Today's High
$1.39
Today's Low
$1.3022
Market Capitalization
$82.5M
Today's Volume
$66.4K
52 Week High
$3.79
52 Week Low
$0.8301
Revenue TTM
$5.0M
EBITDA
$-44.3M
Earnings Per Share (EPS)
$-1.02
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-72.36%

How to invest in Regulus Therapeutics Stock (RGLS) from India?

It is very easy for Indian residents to invest directly in Regulus Therapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Regulus Therapeutics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Regulus Therapeutics or RGLS on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Regulus Therapeutics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Regulus Therapeutics shares which would translate to 0.644 fractional shares of Regulus Therapeutics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Regulus Therapeutics, in just a few clicks!

Returns in Regulus Therapeutics (RGLS) for Indian investors in Rupees

The Regulus Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Regulus Therapeutics investment value today

Current value as on today

₹94,963

Returns

₹5,037

(-5.04%)

Returns from Regulus Therapeutics Stock

₹10,000 (-10%)

Dollar Returns

₹4,963 (+4.96%)

Indian investors sentiment towards Regulus Therapeutics (RGLS)

-50%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Regulus Therapeutics Stock from India on INDmoney has decreased by -50% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Regulus Therapeutics

  • Federated Hermes Inc

    19.62%

  • NEA Management Company, LLC

    9.87%

  • Vivo Capital, LLC

    7.63%

  • Octagon Capital Advisors LP

    7.40%

  • BlackRock Inc

    6.47%

  • Vanguard Group Inc

    6.06%

Analyst Recommendation on Regulus Therapeutics

Buy

    80%Buy

    20%Hold

    0%Sell

Based on 10 Wall street analysts offering stock ratings for Regulus Therapeutics(by analysts ranked 0 to 5 stars)

Based on 10 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
8
8
7
Hold
2
2
2
Sell
0
0
0

Analyst Forecast on Regulus Therapeutics Stock (RGLS)

What analysts predicted

Upside of 665.43%

Target:

$10.33

Current:

$1.35

Insights on Regulus Therapeutics Stock (Ticker Symbol: RGLS)

  • Price Movement

    In the last 1 month, RGLS stock has moved up by 2.3%
  • RGLS vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 62.3% return, outperforming this stock by 71.1%
  • RGLS vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 47.7% return, outperforming this stock by 101.5%
  • Price to Sales

    ForRGLS every $1 of sales, investors are willing to pay $19.0, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $13.8 for every $1 of sales.

Regulus Therapeutics Technicals Summary

Sell

Neutral

Buy

Regulus Therapeutics is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Regulus Therapeutics (RGLS) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Regulus Therapeutics Inc logo
9.76%
-13.46%
-10.0%
-53.77%
-80.88%
Regeneron Pharmaceuticals, Inc. logo
1.3%
-41.29%
-30.51%
9.2%
42.38%
Beone Medicines Ltd logo
15.19%
34.31%
61.3%
43.16%
68.1%
Vertex Pharmaceuticals Incorporated logo
3.37%
3.77%
18.06%
106.43%
121.36%
Alnylam Pharmaceuticals, Inc. logo
-11.52%
-3.4%
62.32%
49.04%
120.93%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Regulus Therapeutics Inc logo
NA
NA
-0.04
-0.87
-0.72
-0.42
NA
1.33
Regeneron Pharmaceuticals, Inc. logo
17.85
17.85
1.03
43.09
0.16
0.07
0.01
273.57
Beone Medicines Ltd logo
NA
NA
NA
1.43
-0.19
-0.06
NA
31.22
Vertex Pharmaceuticals Incorporated logo
32.84
NA
1.33
18.07
-0.03
0.13
NA
63.87
Alnylam Pharmaceuticals, Inc. logo
NA
NA
-0.49
0.57
-15.01
-0.03
NA
0.52
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Regulus Therapeutics Inc logo
Buy
$82.5M
-80.88%
NA
0.0%
Regeneron Pharmaceuticals, Inc. logo
Buy
$74.9B
42.38%
17.85
31.07%
Beone Medicines Ltd logo
NA
$28.5B
68.1%
NA
-16.92%
Vertex Pharmaceuticals Incorporated logo
Buy
$124.1B
121.36%
32.84
-4.86%
Alnylam Pharmaceuticals, Inc. logo
Buy
$31.5B
120.93%
NA
-12.37%

About Regulus Therapeutics

Regulus Therapeutics Inc., a clinical-stage biopharmaceutical company, focuses on discovery and development of drugs that targets microRNAs to treat a range of diseases in the United States. Its product candidates include RGLS8429, an anti-miR next generation oligonucleotide targeting miR-17, which is in Phase 1b clinical trial for the treatment of autosomal dominant polycystic kidney disease. The company is also developing a pipeline of preclinical drug products for target organ-selective delivery strategies. Regulus Therapeutics Inc. was incorporated in 2007 and is headquartered in San Diego, California.
Organization
Regulus Therapeutics
Employees
32
CEO
Mr. Joseph P. Hagan M.B.A.
Industry
Health Technology

Management People of Regulus Therapeutics

NameTitle
Mr. Joseph P. Hagan M.B.A.
CEO & Director
Ms. Crispina Calsada CPA
Chief Financial Officer
Mr. Christopher Ray Aker J.D.
Senior VP, General Counsel & Corporate Secretary
Dr. Preston S. Klassen M.D., M.H.S.
President, Head of Research & Development and Director
Mr. Daniel J. Penksa
VP of Finance & Controller
Dr. Claire Susan Padgett M.S., M.T., Ph.D.
Senior Vice President of Clinical Operations
Dr. Rekha Garg M.D., M.S.
Chief Medical Officer
Mr. Edmund Lee Ph.D.
Vice President of Translational Medicine

Important FAQs about investing in RGLS Stock from India :

What is Regulus Therapeutics share price today?

Regulus Therapeutics share price today stands at $1.35, Open: $1.32 ; Previous Close: $1.35 ; High: $1.39 ; Low: $1.30 ; 52 Week High: $3.79 ; 52 Week Low: $0.83.

The stock opens at $1.32, after a previous close of $1.35. The stock reached a daily high of $1.39 and a low of $1.30, with a 52-week high of $3.79 and a 52-week low of $0.83.

Can Indians buy Regulus Therapeutics shares?

Yes, Indians can invest in the Regulus Therapeutics (RGLS) from India.

With INDmoney, you can buy Regulus Therapeutics at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Regulus Therapeutics at zero transaction cost.

How can I buy Regulus Therapeutics shares from India?

It is very easy to buy Regulus Therapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Regulus Therapeutics (RGLS) be purchased?

Yes, you can buy fractional shares of Regulus Therapeutics with INDmoney app.

What are the documents required to start investing in Regulus Therapeutics stocks?

To start investing in Regulus Therapeutics, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Regulus Therapeutics Stock (RGLS)?

Today’s highest price of Regulus Therapeutics (RGLS) is $1.39.

Today’s lowest price of Regulus Therapeutics (RGLS) is $1.30.

What is today's market capitalisation of Regulus Therapeutics?

Today's market capitalisation of Regulus Therapeutics RGLS is 82.5M

What is the 52 Week High and Low Range of Regulus Therapeutics Stock (RGLS)?

  • 52 Week High

    $3.79

  • 52 Week Low

    $0.83

What are the historical returns of Regulus Therapeutics (RGLS)?

  • 1 Month Returns

    9.76%

  • 3 Months Returns

    -13.46%

  • 1 Year Returns

    -10%

  • 5 Years Returns

    -80.88%

Who is the Chief Executive Officer (CEO) of Regulus Therapeutics ?

Mr. Joseph P. Hagan M.B.A. is the current Chief Executive Officer (CEO) of Regulus Therapeutics.